crystalline forms a, b, c, ex, process for preparing crystalline forms a, b, c, ex pharmaceutical formulation, use of forms a, b, c, ex, and process for preparing the amorphous form of (r) hydrochloride -5- (2-aminoethyl) -1- (6,8-difluorochroman-3-yl) -1,3-dihydroimidazole-2-thione

摘要

CRYSTALLINE FORMS A, E, C, EX, PROCESS TO PREPARE CRYSTALLINE FORMS A, B, C, EX, PHARMACEUTICAL FORMULATION, USE OF FORMS A, B, C, EX, AND PROCESS TO PREPARE THE AMORPHIC CHLORIDATE FORM OF (R ) -5- (2-AMINOETHIL) -1- (6,8-DIFLUOROCROMAN-3-IL) -1,3-DIIDROIMIDAZOL -2-TIONA. (R) -5- (2-Aminoethyl) -1- (6,8-difluorochroman-3-yl) -1,3-dihydroimidazole-2-thione hydrochloride polymorphs and methods for their preparation.